Serostim Off-Label Use Under Scrutiny; Prosecutor Looks At Job Descriptions
Executive Summary
The Boston U.S. Attorney's Office may be looking at employee job descriptions or performance criteria in its investigations of off-label promotion
You may also be interested in...
Serono Nears Settlement In Serostim Investigation, Sets Aside $725 Mil.
Serono is setting aside $725 mil. to settle federal and state claims related to pricing and marketing practices for the AIDS wasting therapy Serostim (human growth hormone)
Serono Nears Settlement In Serostim Investigation, Sets Aside $725 Mil.
Serono is setting aside $725 mil. to settle federal and state claims related to pricing and marketing practices for the AIDS wasting therapy Serostim (human growth hormone)
Serostim Sales Plan Included Physician Kickbacks, Government Alleges
Serono sales managers created a plan offering physicians financial incentives to prescribe Serostim in numbers needed to achieve sales goals, an information filed by Boston U.S. Attorney Michael Sullivan alleges